Katherine,If you are doing a dark iris, no iris vessels will be visible with FA, unless there is something obvious, like rubeosis. For conjunctival FA, turn power way down and watch the exposure on the monitor. The first JOPS had an article by Csaba Martonyi about a conjunctival FA done with a Zeiss slit lamp.
Fluorescein Angio-Photography of the Conjunctiva, Martonyi CL. 10/1978 Vol 1:1 p.14 PDF (96k) (should be accessible on the OPS website).
The Topcon retinal camera gives good anterior segment sharpness (better that the Zeiss FF-3, don't know about the current Zeiss cameras). I use either 35 or 20 degrees depending. Like Sandor, focus by moving the base. If the knob is focused all the way anterior, more mag and sometimes more distortion and less resolution. All the way posterior, less mag, less distortion and more resolution. The lower magnification can be compensated for zooming on the monitor.
Tom Quoting Sandor Ferenczy <sandorferenczy@xxxxxxxxx>:
Katherine, it is pretty simple - i usually focus as anteriorly as i can, set mag to 35 degrees and focus by moving the camera away from/towards the patient (similar to a slit lamp) exposure will need to be set way down, as the white conj will blowout very quickly. our exposure for a darker iris isnt usually much different than the retina, but it can be almost impossible to get proper exposure for both the conj and iris, so be ready to adjust flash level on the fly as you switch between conj and iris. -sandor Sandor Ferenczy, CRA, OCTc Director of Ophthalmic Photography Ocular Oncology Service Wills Eye Institute 840 Walnut Street, 14th Floor Philadelphia, Pa 19107 www.fighteyecancer.com On Wed, May 29, 2013 at 11:25 AM, Lee, Katherine K. <leek@xxxxxxxx> wrote:We may be asked to do an FA on a patient with recurring sub-conj. hemorrhages. Our retina doc says he wants a "conjunctival FA" We have a zeiss camera with OIS software, lots of fundus FA experience but really no iris FA experience. Any insight you could share would be appreciated Katherine K Lee COT Storm Eye Institute 843-792-2764 fax 792-8865 pager 17576 If you have received this communication in error, please notify the sender immediately. The documents accompanying this facsimile/electronic transmission contain confidential information intended only for the use of the individual or entity to which it is addressed and may contain information that is privileged, confidential, and exempt from disclosure. If the reader of this message is not the intended recipient, or an employee responsible for delivering the message to the intended recipient, you are hereby notified that any disclosure, dissemination, distribution, or copying of this communication is strictly prohibited. ------------------------------ *From:* optimal-bounce@xxxxxxxxxxxxx [optimal-bounce@xxxxxxxxxxxxx] On Behalf Of Breit, Peter [BreitP@xxxxxxxx] *Sent:* Wednesday, May 29, 2013 9:54 AM *To:* optimal@xxxxxxxxxxxxx *Subject:* [optimal] FW: IVFA Fluorescein approved versions Just for your info in case a patient or doc asked for clarification , I believe that was sent by one of you a short while ago. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/ucm280534.htm *Thank you* *Peter* Peter L. Breit, CRA. Director Ophthalmic Services The Lankenau Hospital & Bryn Mawr Hospital 484-476-3338 484-476-8206 fax 484-437-3262 mobile page 3707